-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QwZDsqTdI7ZpYKNNDRee5aLTLb5il7vSD/4WI+m0xDRV8I4m1HaME7JVzUJioYRf WGSPILiAkbWSuqNJhoA6xQ== 0000950109-97-007169.txt : 19971127 0000950109-97-007169.hdr.sgml : 19971127 ACCESSION NUMBER: 0000950109-97-007169 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19971126 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANIKA THERAPEUTICS INC CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-38993 FILM NUMBER: 97728731 BUSINESS ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 6179326616 MAIL ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 424B3 1 FORM 424(B)(3) PROSPECTUS SUPPLEMENT DATED NOVEMBER 26, 1997 [ANIKA LOGO APPEARS HERE] Anika Therapeutics, Inc. (the "Company") calls your attention to the disclosure under the caption "Business--Legal Proceedings" on page 42 of its Prospectus dated November 25, 1997, in which the Company refers to certain correspondence received from a competitor. The Company has been informed subsequent to the preparation of the Prospectus, that on November 25, 1997, the competitor, Biomatrix, Inc., filed a complaint against the Company in the United States District Court for the District of Massachusetts seeking injunctive relief and damages with respect to certain of the claims made in the correspondence. Such claims allege, among other things, that the Company has made false and misleading statements about a Biomatrix product and one of the Company's products. The Company believes that these claims are without merit and will vigorously seek to protect its rights regarding such claims. While the Company is still investigating the matter, it does not believe the matter will have a material adverse effect on its business, financial position or results of operations. -----END PRIVACY-ENHANCED MESSAGE-----